Filing Flows › CorMedix (CRMD) › Q4 2024
CorMedix (CRMD) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 25, 2025
CorMedix (CRMD) reported revenue of $31.2M for the fourth quarter 2024 (Q4 2024) and +172% from the quarter before. Operating margin was 41.4%, net earnings $13.5M (43.1% of revenue).
CorMedix, Q4 2024: revenue $31.2M, operating margin 41.4%, net earnings $13.5M, operating cash flow −$5.6M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.2M | +172% | — |
| Gross profit | $30.0M | +179% | — |
| Operating profit | $12.9M | — | — |
| Net earnings | $13.5M | — | — |
| Operating cash flow | −$5.6M | — | — |
What changed
Revenue was $31.2M in Q4 2024, up 172% from the previous quarter.
Gross margin was 96.2%. Operating profit was $12.9M, a 41.4% margin. Net earnings were $13.5M. The effective tax rate was 0.0%.
Operating cash flow was −$5.6M. Non-cash charges added back $134K of depreciation and amortization and $1.2M of share-based compensation. Working capital and other items used $20.4M. Capital expenditures of $10K exceeded it, leaving free cash flow of −$5.6M.
Questions
What was CorMedix's revenue in the fourth quarter 2024?
CorMedix (CRMD) reported revenue of $31.2M for the fourth quarter 2024 (Q4 2024) and +172% from the quarter before.
Was CorMedix profitable in the fourth quarter 2024?
Operating profit was $12.9M (41.4% of revenue) and net earnings $13.5M.
Source: CorMedix 10-K on SEC EDGAR.